What Is Neurofeedback?
AbstractEEG biofeedback (neurofeedback) originated in the late 1960s as a method for retraining brainwave patterns through operant conditioning. Since that time a sizable body of research has accumulated on the effectiveness of neurofeedback in the treatment of uncontrolled epilepsy, ADD/ADHD, anxiety, alcoholism, posttraumatic stress disorder, and mild head injuries. Studies also provide encouraging indications that neurofeedback offers a treatment alternative for use with learning disabilities, stroke, depression, fibromyalgia, autism, insomnia, tinnitus, headaches, problems with physical balance, and for the enhancement of peak performance. At a time when an increasing number of people are concerned with negative effects from relying solely on medication treatments, neurofeedback may offer an additional treatment alternative for many conditions. This article assists the reader to understand how neurofeedback works, how assessment allows neurofeedback to be individualized, and briefly reviews evidence for the neurofeedback treatment of many conditions. The public is cautioned that in selecting a practitioner for the treatment of the kinds of medical, psychiatric and psychological conditions cited above, a practitioner should be licensed for independent practice in their state or province and should ideally also be certified by a legitimately recognized body.
© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article. From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).